APA (7th ed.) Citation

HD, R., J, M., J, G., EJ, D., Y, Z., KW, T., . . . KK, L. (2017). High stathmin expression is a marker for poor clinical outcome in endometrial cancer: An NRG oncology group/gynecologic oncology group study. Gynecologic oncology, 146(2), 247. https://doi.org/10.1016/j.ygyno.2017.05.017

Chicago Style (17th ed.) Citation

HD, Reyes, et al. "High Stathmin Expression Is a Marker for Poor Clinical Outcome in Endometrial Cancer: An NRG Oncology Group/gynecologic Oncology Group Study." Gynecologic Oncology 146, no. 2 (2017): 247. https://doi.org/10.1016/j.ygyno.2017.05.017.

MLA (9th ed.) Citation

HD, Reyes, et al. "High Stathmin Expression Is a Marker for Poor Clinical Outcome in Endometrial Cancer: An NRG Oncology Group/gynecologic Oncology Group Study." Gynecologic Oncology, vol. 146, no. 2, 2017, p. 247, https://doi.org/10.1016/j.ygyno.2017.05.017.